3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine
Modify Date: 2024-02-04 20:26:34
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine structure
|
Common Name | 3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine | ||
|---|---|---|---|---|
| CAS Number | 128495-99-8 | Molecular Weight | 453.42 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 617.3±65.0 °C at 760 mmHg | |
| Molecular Formula | C23H20FN3O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 327.1±34.3 °C | |
Use of 3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 4-Amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-2(1H)-pyrimidinone |
|---|---|
| Synonym | More Synonyms |
| Description | 3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 617.3±65.0 °C at 760 mmHg |
| Molecular Formula | C23H20FN3O6 |
| Molecular Weight | 453.42 |
| Flash Point | 327.1±34.3 °C |
| Exact Mass | 453.133606 |
| LogP | 3.78 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.643 |
| 2(1H)-Pyrimidinone, 4-amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)- |
| MFCD25542521 |
| 4-Amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-2(1H)-pyrimidinone |